Gladius Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-290	Closed	-$32.3K	–	122
2024 Q3	$32.3K	Sell	290 -19	-6%	-$2.12K	﹤0.01%	161
2024 Q2	$33K	Buy	+309	New	+$33K	﹤0.01%	158
2022 Q3	–	Sell	-210	Closed	-$33K	–	374
2022 Q2	$33K	Buy	+210	New	+$33K	﹤0.01%	231